openPR Logo
Press release

Researchers United to Find a HIV cure

04-15-2011 11:34 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Informed Horizons, LLC

HIV persistence is an area of importance to many scientists working on a possible cure for HIV, and every two years a reference workshop is held to bring the world's top scientists together for a meeting of the minds. Researchers from several different fields will therefore attend its next edition, December 6-9, 2011. The preliminary program of this workshop has just been released, and the four-day seminar is packed with intelligent dialogue and important research, all working toward the goal of eventual HIV cure.

Toulon, France, April 15, 2011 -- After the welcoming address given by Mario Stevenson (University of Miami, USA), the workshop is divided into blocks over the course of the next three days. These blocks, generally 90-120 minutes in length, feature several research abstracts pertaining to the same topic. This makes it very easy for guests to follow along with what's going on, and when.

On Wednesday, December 7, there are 3 blocks: ‘Models of HIV Persistence’, ‘Basic Science of HIV Persistence’, and a 2-hour presentation on the ‘Virological Aspects of HIV Persistence’. Included in these 3 blocks, as well as the others on subsequent days, are additional abstracts submitted by other scientists not scheduled to speak during the block.

On Thursday, December 8, several different blocks populate the longest day of the workshop. It starts at 8:00 am with ‘Innate Immunity & HIV Persistence’, followed by a 90-minute presentation on ‘Immune Control of HIV Reservoirs’. After an hour-long presentation from the firms supporting the workshop, the afternoon/evening session consists of two major blocks discussion about ‘Acute HIV Infection’ and ‘Anatomic HIV Reservoirs’. As before, additional abstracts will be discussed during the session block as time allows.

The final day, Friday, December 9, wraps things up with two morning presentation blocks on the ‘New Approaches Towards HIV Eradication’. These two discussion blocks are 2 hours each, separated by a half-hour break in between. The 8:00 session features such discussions about therapeutic intervention as it pertains to HIV infection and the various strategies targeting HIV reservoirs. The second 2-hour session, which is the final session of the workshop, is highlighted by two discussions on the CCR5 gene and the disruption of that gene that has yielded some important research in finding a possible cure for HIV.

The workshop will be closed by Doctor Alain Lafeuillade, MD and Françoise Barre-Sinoussi, 2008 Nobel Laureate for Medicine and International AIDS Society (IAS) President-Elect.

About the HIV Persistence Workshop:

The workshop will be closed by Doctor Alain Lafeuillade, MD and Françoise Barre-Sinoussi, 2008 Nobel Laureate for Medicine and International AIDS Society (IAS) President-Elect.

Alain Lafeuillade
Informed Horizons, LLC
General Hospital
Toulon, France

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Researchers United to Find a HIV cure here

News-ID: 171153 • Views: 1630

More Releases from Informed Horizons, LLC

Scientists Move Towards A HIV Cure
Dr. Alain Lafeuillade and Dr. Mario Stevenson, are pleased to announce the 5th International Workshop on HIV Persistence During Therapy, to be held December 6-9, 2011 in St Maarten, West Indies. The Workshop will be of invaluable importance for scientists working towards a HIV cure. Toulon, France, May 29, 2011 -- Dr. Alain Lafeuillade, Toulon, France and Dr. Mario Stevenson, University of Miami, USA are pleased to announce the 5th International
Hope for a Cure Against HIV
Alain Lafeuillade (France) and Mario Stevenson (USA) co-authored a paper on HIV reservoirs that claims these reservoirs are the main hurdle to achieving HIV eradication. This paper provides information on the mechanisms of HIV persistence and a discussion on the critical questions facing researchers in the field. Tucker, GA, May 28, 2011 -- Alain Lafeuillade (France) and Mario Stevenson (USA) co-authored a paper on HIV reservoirs that claims these reservoirs are
New Discoveries Expected at the Scientific Workshop on HIV Reservoirs
Tucker, GA - April 21, 2011 -- Controlling HIV replication without the need of life-long antiretroviral therapy (ART) is the next frontier scientists are addressing. Researchers involved in the fields of HIV reservoirs and eradication have just released the preliminary program of a workshop they will organize later this year, where scientific breakthroughs are expected. Fifteen years ago, when ART was discovered, a renewed optimism for a cure gained several scientists
Scientists Work for a HIV Functional Cure
Tucker, GA - April 12, 2011 -- Researchers have just unveiled the advanced program of the reference workshop on ‘HIV Persistence, Reservoirs & Eradication Strategies’ to be held later this year in Sin Maarten. Since 2003, a group of scientists from different fields and countries address the issue of why HIV persists in infected individuals despite antiretroviral therapy (ART) and how it could be attacked in its reservoirs to achieve a

All 5 Releases

More Releases for HIV

Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral